NanoBioPhysics and Medical Physics (Prof. Tilman Schäffer)
Welcome to the homepage of the BioForce Group
In our group we
research physics at the interface to biology and medicine. For this purpose, we
- measure mechanical and electrical parameters of nanosystems
- develop novel instruments for high resolution microscopy and medical diagnosis
Current projects:
- visualizing morphological and mechanical properties of living cells and tissues
- differentiating cancerous tissue using water flow elastography
- illuminating transport processes in artificial and natural membranes
- exposing biomaterials on the molecular scale

News
11/2022   |
Add-on Fellowship for Interdisciplinary Life Science by the Joachim Herz Foundation awarded to Aylin Balmes |
09/2019   |
Poster award at the conference "AFM BioMed", Münster, to Johannes Rheinlaender |
02/2019   |
Cover of the journal 'Soft Matter' with Johannes Rheinlaender's 3D-image of a live cell |
08/2018   |
Cover of the journal 'Applied Physics Letters' with Marc Schächtele's 3D-image of a live cell |
05/2018   |
Award 'Best Study Course' in the graduate program 'Biomedical Technologies' to Johannes Rheinlaender and Tilman Schäffer |
09/2017   |
Award for the best poster at the symposium "Novel tools to investigate cellular physiology at the nanoscale", Bochum, to Jan Seifert |
07/2017   |
Award 'Best Lecture Series in Pre-Clinical Studies (3rd place)' to Tilman Schäffer |
07/2017   |
Award 'Best Instructor' in the graduate program 'Biomedical Technologies' to Johannes Rheinlaender |
04/2016   |
Award for the best oral presentation at the AFM BioMed conference, Porto, to Nicolas Schierbaum |
07/2015   |
Doctoral Award from the Faculty of Science to Christoph Braunsmann |
07/2015   |
Award for the best poster at the 10th European Biophysical Societies' Association (EBSA) Congress, Dresden, to Nicolas Schierbaum |
06/2015   |
Cover of the journal 'Soft Matter' with Nicolas Schierbaum's 3D-image of a live cell |
05/2015   |
Award 'Best Instructor' in the graduate program 'Biomedical Technologies' to Johannes Rheinlaender |